All types of atrial fibrillation in the setting of myocardial infarction are associated with impaired outcome

Heart

Volumn 102, Issue 12, 2016, Pages 926-933

  Batra, Gorav ^a   Svennblad, Bodil ^a   Held, Claes ^a   Jernberg, Tomas ^b   Johanson, Per ^c   Wallentin, Lars ^a   Oldgren, Jonas ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ATRIAL FIBRILLATION; BRAIN ISCHEMIA; CARDIOVASCULAR MORTALITY; CHRONIC ATRIAL FIBRILLATION; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ANGIOGRAPHY; DISEASE CLASSIFICATION; ELECTROCARDIOGRAPHY; FEMALE; HEART REINFARCTION; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PAROXYSMAL ATRIAL FIBRILLATION; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SINUS RHYTHM; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; AGED; CAUSE OF DEATH; COMORBIDITY; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; NON-ST ELEVATED MYOCARDIAL INFARCTION; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RECURRENT DISEASE; REGISTER; RISK ASSESSMENT; RISK FACTOR; ST ELEVATION MYOCARDIAL INFARCTION; STROKE; SWEDEN; TIME FACTOR; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; BRAIN ISCHEMIA; CAUSE OF DEATH; COMORBIDITY; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NON-ST ELEVATED MYOCARDIAL INFARCTION; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RECURRENCE; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; ST ELEVATION MYOCARDIAL INFARCTION; STROKE; SWEDEN; TIME FACTORS;

EID: 84960914507     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2015-308678     Document Type: Article

References (27)

1. Krijthe BP, Kunst A, Benjamin EJ, et al. Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060. Eur Heart J 2013;34:2746-51
2. Schmitt J, Duray G, Gersh BJ, et al. Atrial fibrillation in acute myocardial infarction: A systematic review of the incidence, clinical features and prognostic implications. Eur Heart J 2009;30:1038-45
3. Pizzetti F, Turazza FM, Franzosi MG, et al. Incidence and prognostic significance of atrial fibrillation in acute myocardial infarction: the GISSI-3 data. Heart 2001;86:527-32
4. Wong C-K, White HD, Wilcox RG, et al. New atrial fibrillation after acute myocardial infarction independently predicts death: the GUSTO-III experience. Am Heart J 2000;140:878-85
5. Crenshaw BS, Ward SR, Granger CB, et al. Atrial fibrillation in the setting of acute myocardial infarction: the GUSTO-I experience. Global utilization of streptokinase and TPA for occluded coronary arteries. J Am Coll Cardiol 1997;30:406-13
6. Mehta RH, Dabbous OH, Granger CB, et al. Comparison of outcomes of patients with acute coronary syndromes with and without atrial fibrillation. Am J Cardiol 2003;92:1031-6
7. Lopes RD, Pieper KS, Horton JR, et al. Short-and long-term outcomes following atrial fibrillation in patients with acute coronary syndromes with or without ST-segment elevation. Heart 2008;94:867-73
8. Jernberg T, Attebring MF, Hambraeus K, et al. The Swedish Web-system for Enhancement and Development of Evidence-based care in Heart disease Evaluated According to Recommended Therapies (SWEDEHEART). Heart 2010;96:1617-21
9. Ludvigsson JF, Andersson E, Ekbom A, et al. External review and validation of the Swedish national inpatient register. BMC Public Health 2011;11:450
10. Smith JG, Platonov PG, Hedblad B, et al. Atrial fibrillation in the Malmö Diet and Cancer study: A study of occurrence, risk factors and diagnostic validity. Eur J Epidemiol 2010;25:95-102
11. Lip GYH, Nieuwlaat R, Pisters R, et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 2010;137:263-72
12. Goldberg RJ, Yarzebski J, Lessard D, et al. Recent trends in the incidence rates of and death rates from atrial fibrillation complicating initial acute myocardial infarction: A community-wide perspective. Am Heart J 2002;143:519-27
13. Pedersen OD, Bagger H, Køber L, et al. The occurrence and prognostic significance of atrial fibrillation/-flutter following acute myocardial infarction. Eur Heart J 1999;20:748-54
14. Maagh P, Butz T, Wickenbrock I, et al. New-onset versus chronic atrial fibrillation in acute myocardial infarction: differences in short-and long-term follow-up. Clin Res Cardiol 2011;100:167-75
15. Laurent G, Dentan G, Moreau D, et al. Atrial fibrillation during myocardial infarction with and without ST segment elevation. Arch Mal Coeur Vaiss 2005;98:608-14
16. Steg PG, Goldberg RJ, Gore JM, et al. Baseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE). Am J Cardiol 2002;90:358-63
17. Eldar M, Canetti M, Rotstein Z, et al. Significance of paroxysmal atrial fibrillation complicating acute myocardial infarction in the thrombolytic era. Circulation 1998;97:965-70
18. Rathore SS, Berger AK, Weinfurt KP, et al. Acute myocardial infarction complicated by atrial fibrillation in the elderly: prevalence and outcomes. Circulation 2000;101:969-74
19. Lehto M, Snapinn S, Dickstein K, et al. Prognostic risk of atrial fibrillation in acute myocardial infarction complicated by left ventricular dysfunction: the OPTIMAAL experience. Eur Heart J 2005;26:350-6
20. Nattel S, Burstein B, Dobrev D. Atrial remodeling and atrial fibrillation: mechanisms and implications. Circ Arrhythmia Electrophysiol 2008;1:62-73
21. Lopes RD, Elliott LE, White HD, et al. Antithrombotic therapy and outcomes of patients with atrial fibrillation following primary percutaneous coronary intervention: results from the APEX-AMI trial. Eur Heart J 2009;30:2019-28
22. Siu CW, Jim MH, Ho HH, et al. Transient atrial fibrillation complicating acute inferior myocardial infarction: implications for future risk of ischemic stroke. Chest 2007;132:44-9
23. Connolly S, Pogue J, Hart R, et al. Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): A randomised controlled trial. Lancet 2006;367:1903-12
24. Soliman EZ, Safford MM, Muntner P, et al. Atrial fibrillation and the risk of myocardial infarction. JAMA Intern Med 2014;174:107-14
25. Soliman EZ, Lopez F, O'Neal WT, et al. Atrial fibrillation and risk of ST-segment-elevation versus non-ST-segment-elevation myocardial infarction: The Atherosclerosis Risk in Communities (ARIC) Study. Circulation 2015;131:1843-50
26. Aviles RJ, Martin DO, Apperson-Hansen C, et al. Inflammation as a risk factor for atrial fibrillation. Circulation 2003;108:3006-10
27. Ridker PM, Rifai N, Stampfer MJ, et al. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000;101:1767-72.